GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aeolus Pharmaceuticals Inc (OTCPK:AOLS) » Definitions » Accounts Payable & Accrued Expense for Financial Companies

AOLS (Aeolus Pharmaceuticals) Accounts Payable & Accrued Expense for Financial Companies


View and export this data going back to 1996. Start your Free Trial

What is Aeolus Pharmaceuticals Accounts Payable & Accrued Expense for Financial Companies?

Accounts Payable & Accrued Expense for Financial Companies only applies to insurance companies.

Aeolus Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aeolus Pharmaceuticals Inc (OTCPK:AOLS) » Definitions » Accounts Payable & Accrued Expense for Financial Companies
Comparable Companies
RDGL BOM:524590 TSXV:CIP.H BOM:524606 FRA:3SQ1 BOM:532021 BOM:540359 BOM:531686 BOM:531521 BOM:539680 PCYN BOM:531015 BOM:524516 BOM:524314 BOM:511523 YBAO WAR:SP1 BOM:532167 BOM:524632 HPMM
Traded in Other Exchanges
N/A
Address
26361 Crown Valley Parkway, Suite 150, Mission Viejo, CA, USA, 92691
Website
http://www.aolsrx.com
Aeolus Pharmaceuticals Inc is a Southern California-based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.
Executives
John L Mcmanus officer: President and CEO C/O AEOLUS PHARMACEUTICALS, INC., 26361 CROWN VALLEY PARKWAY, SUITE 150, MISSION VIEJO CA 92691
Chris A Rallis director C/O TENAX THERAPEUTICS, INC., ONE COPLEY PARKWAY, SUITE 490, MORRISVILLE NC 27560
Amit Kumar director C/O ACACIA RESEARCH CORPORATION, 500 NEWPORT CENTER DRIVE, 7TH FLOOR, NEWPORT BEACH CA 92660
Joseph J Krivulka director C/O DANCE BIOPHARM INC., 150 NORTH HILL DRIVE, SUITE 24, BRISBANE CA 94005
David Cavalier director C/O AEOLUS PHARMACEUTICALS, INC., 23811 INVERNESS PLACE, LAGUNA NIGUEL CA 92677
Michael E Lewis director C/O CARA THERAPEUTICS, INC., 1 PARROTT DRIVE, SHELTON CT 06484
Peter David Suzdak director 1204 MEADOWLARK DRIVE, TOWSON MD 21286
Russell Skibsted officer: Chief Financial Officer 15 TRANQUILITY PLACE, LADERA RANCH CA 92694
Mark Lappe 10 percent owner 11622 EL CAMINO REAL, SUITE 100, SAN DIEGO CA 92130
Bvf Investments Llc 10 percent owner, other: Indirect Beneficial Owner 1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104
Biotechnology Value Fund Ii Lp 10 percent owner, other: Indirect Beneficial Owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Inc/il 10 percent owner, other: Indirect Beneficial Owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Partners L P/il 10 percent owner, other: Indirect Beneficial Owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Biotechnology Value Fund L P 10 percent owner, other: Indirect Beneficial Owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Jon Faiz Kayyem 10 percent owner 5964 LA PLACE COURT, CARLSBAD CA 92008